CHARLOTTE, N.C., Nov. 4, 2019 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD) - Team cbdMD MMA fighter Jorge Masvidal earned the inaugural "BMF" title belt Saturday night in Madison Square Garden, defeating Nate Diaz in the highly anticipated UFC 244 headliner.
Masvidal, coming off of the fastest knockout decision victory in UFC history this past June, dominated Diaz via third-round TKO at the main event. A severe cut over the eye of Diaz led to the ringside physician waving the fight early, surprising many who watched the bout.
The UFC 244 headliner came about after Diaz defeated former lightweight champion Anthony Pettis at UFC 241. He called out Jorge Masvidal as the next fight he wanted to have, acknowledging he was the only real fighter he wanted to take on within the division. The UFC then put together its first-ever "BMF" championship fight.
The pay-per-view event at Madison Square Garden was Masvidal's third straight win, boasting an undefeated record in 2019, while his overall record is now 35-13.
"The cbdMD bath bombs helped me get through my training camp," said Jorge Masvidal. They were an amazing addition to help me get ready for this fight."
"Jorge is known for his intimidating presence, but his drive and determination also make him one of the best MMA fighters alive," said Caryn Dunayer, president of cbdMD. "Brand exposure at a marquee event like UFC 244 is obviously great, but we're just as proud that our products produce results for fighters like Jorge."
cbdMD, Inc. is a nationally recognized consumer cannabidiol (CBD) brand whose current products include CBD tinctures, CBD gummies, CBD topicals, CBD bath bombs, and CBD pet products. cbdMD is also the proud partner with the BIG3 Basketball League, Barstool Sports, Bellator MMA, Life Time, Inc. and Nitro Circus. cbdMD has one of the largest rosters of professional sports athletes who are part of "Team cbdMD." To learn more about cbdMD and our comprehensive line of over 100 SKUs of U.S. produced, THC-free CBD products, please visit: www.cbdmd.com or follow cbdMD on Instagram and Facebook or visit one of the 3,000 retail outlets that carry cbdMD products.
This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as ''should,'' ''may,'' ''intends,'' ''anticipates,'' ''believes,'' ''estimates,'' ''projects,'' ''forecasts,'' ''expects,'' ''plans,'' and ''proposes.'' These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, including, but not limited our ability to, our ability to expand our sales of our CBD products through our partnership with Jorge Masvidal, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading "Risk Factors" in cbdMD, Inc.'s Annual Report on Form 10-K for the fiscal year ended September 30, 2018, as filed with the Securities and Exchange Commission (the "SEC") on December 12, 2018, our Quarterly Report on Form 10-Q for the period ended March 31, 2019, as filed with the SEC on May 15, 2019, our Quarterly Report on Form 10-Q for the period ended June 30, 2019 as filed with the SEC on August 14, 2019 and our other filings with the SEC. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of cbdMD, Inc. and are difficult to predict. cbdMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release. The information which appears on Jorge Masvidal's social media platforms is not part of this press release.
1 (800) 973-3984